New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 1, 2013
10:16 EDTBMRNBioMarin achondroplasia treatment granted orphan designation by EMA
Orphan designation granted by the European Commission to BioMarin Europe for modified recombinant human C-type natriuretic peptide for the treatment of achondroplasia on Jan. 24, according to posting to European Medicines Agency site. Reference Link
News For BMRN From The Last 14 Days
Check below for free stories on BMRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for BMRN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use